On Friday, CERo Therapeutics Holdings Inc (NASDAQ: CERO) was -19.81% drop from the session before settling in for the closing price of $1.11. A 52-week range for CERO has been $0.53 – $171.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 59.83%. With a float of $3.81 million, this company’s outstanding shares have now reached $5.60 million.
In terms of profitability, gross margin is 0.0%, operating margin of -1392.99%, and the pretax margin is -953.65%.
CERo Therapeutics Holdings Inc (CERO) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward CERo Therapeutics Holdings Inc stocks. The insider ownership of CERo Therapeutics Holdings Inc is 31.95%, while institutional ownership is 4.62%. The most recent insider transaction that took place on Dec 13 ’24, was worth 179,934. In this transaction 10% Owner of this company sold 2,998,908 shares at a rate of $0.06, taking the stock ownership to the 13,005,169 shares. Before that another transaction happened on Dec 12 ’24, when Company’s 10% Owner sold 1,614,541 for $0.07, making the entire transaction worth $113,018. This insider now owns 16,004,077 shares in total.
CERo Therapeutics Holdings Inc (CERO) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 59.83% per share during the next fiscal year.
CERo Therapeutics Holdings Inc (NASDAQ: CERO) Trading Performance Indicators
You can see what CERo Therapeutics Holdings Inc (CERO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -38.99 and is forecasted to reach -0.86 in one year’s time.
Technical Analysis of CERo Therapeutics Holdings Inc (CERO)
Looking closely at CERo Therapeutics Holdings Inc (NASDAQ: CERO), its last 5-days average volume was 15.14 million, which is a jump from its year-to-date volume of 1.72 million. As of the previous 9 days, the stock’s Stochastic %D was 62.18%. Additionally, its Average True Range was 0.17.
During the past 100 days, CERo Therapeutics Holdings Inc’s (CERO) raw stochastic average was set at 1.74%, which indicates a significant decrease from 40.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 215.58% in the past 14 days, which was higher than the 189.63% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1126, while its 200-day Moving Average is $8.5379. However, in the short run, CERo Therapeutics Holdings Inc’s stock first resistance to watch stands at $0.9718. Second resistance stands at $1.0536. The third major resistance level sits at $1.1243. If the price goes on to break the first support level at $0.8193, it is likely to go to the next support level at $0.7486. Should the price break the second support level, the third support level stands at $0.6668.
CERo Therapeutics Holdings Inc (NASDAQ: CERO) Key Stats
There are 3,030K outstanding shares of the company, which has a market capitalization of 4.98 million. As of now, sales total 0 K while income totals -8,300 K. Its latest quarter income was 0 K while its last quarter net income were 670 K.
